Wake Forest University Health Sciences: Brain Neoplasms trials

The registry lists 14 Brain Neoplasms studies with Wake Forest University Health Sciences as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 7Phase 3 2No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Reducing the Incidence of Symptomatic Brain Metastases With MRI SurveillanceRecruitingNCT05692635Phase 2
• Testing Ramipril to Prevent Memory Loss in People With GlioblastomaCompletedNCT03475186Phase 2Results posted
• A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)TerminatedNCT02343549Phase 2Results posted
• A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade GliomasCompletedNCT01188096Phase 2Results posted
• Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain TumorsCompletedNCT01032200Phase 2Results posted
• Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain TumorsCompletedNCT00369785Phase 3Results posted
• Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving ImmunotherapyActive, not recruitingNCT05703269Not applicable
• Electronic Medical Record Review in Monitoring the Effects of Adherence on Myelosuppression and Morbidity in Patients With Newly Diagnosed Brain Tumors Receiving Temozolomide and Radiation TherapyCompletedNCT02208336
• Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung CancerWithdrawnNCT02014545Phase 2
• Yoga Therapy in Treating Patients With Malignant Brain TumorsTerminatedNCT01234805Not applicable
• Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain TumorsCompletedNCT01151670Phase 1
• Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsCompletedNCT00499798
• Radiation Therapy Plus Thalidomide and Temozolomide in Treating Patients With Newly Diagnosed Brain MetastasesCompletedNCT00049361Phase 2
• Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain TumorsTerminatedNCT00031798Phase 3